Scleroderma and failed response to alefacept.
G C-L
GC
Chi
F-S
FS
Hsu
C-C
CC
Yang
J C-C
JC
Wei
D000077944:Alefacept; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008875:Middle Aged; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use*; D012595:Scleroderma, Systemic / Q000188:drug therapy*; D017211:Treatment Failure
D018501:Antirheumatic Agents; D011993:Recombinant Fusion Proteins; D000077944:Alefacept